← Back to headlines
Gossamer Bio's Lung Condition Drug Fails Late-Stage Trial
Gossamer Bio's experimental drug for a lung condition has reportedly failed in its late-stage clinical trial, impacting the company's prospects.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
